Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Centre hospitalier universitaire (CHU) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
30 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
106.4 rhumatos / 100 000 hab. — département bien doté
27 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Influence scientifique
8
8 articles ont été cités au moins 8fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
440
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
47
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
8
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
CHU DE MARTINIQUE SITE P.ZOBDA QUITMAN
QUA LA MEYNARD CS 90632, 97261 FORT DE FRANCE CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
JAMA network open · 2023
ImportanceThe number of deaths of children younger than 5 years has been steadily decreasing worldwide, from more than 17 million annual deaths in the 1970s to an estimated 5.3 million in 2019 (with 2.8 million deaths occurring in those aged 1-59 months [53% of all deaths in children aged <5 years]). More detailed characterization of childhood deaths could inform interventions to improve child survival.ObjectiveTo describe causes of postneonatal child deaths across 7 mortality surveillance sentinel sites in Africa and Asia.Design, Setting, and ParticipantsThe Child Health and Mortality Prevention Surveillance (CHAMPS) Network conducts childhood mortality surveillance in sub-Saharan Africa and South Asia using innovative postmortem minimally invasive tissue sampling (MITS). In this cross-sectional study, MITS was conducted in deceased children aged 1 to 59 months at 7 sites in sub-Saharan Africa and South Asia from December 3, 2016, to December 3, 2020. Data analysis was conducted between October and November 2021.Main Outcomes and MeasuresThe expert panel attributed underlying, intermediate, and immediate conditions in the chain of events leading to death, based on histopathologic analysis, microbiological diagnostics, clinical data, and verbal autopsies.ResultsIn this study, MITS was performed in 632 deceased children (mean [SD] age at death, 1.3 [0.3] years; 342 [54.1%] male). The 6 most common underlying causes of death were malnutrition (104 [16.5%]), HIV (75 [11.9%]), malaria (71 [11.2%]), congenital birth defects (64 [10.1%]), lower respiratory tract infections (LRTIs; 53 [8.4%]), and diarrheal diseases (46 [7.2%]). When considering immediate causes only, sepsis (191 [36.7%]) and LRTI (129 [24.8%]) were the 2 dominant causes. An infection was present in the causal chain in 549 of 632 deaths (86.9%); pathogens most frequently contributing to infectious deaths included Klebsiella pneumoniae (155 of 549 infectious deaths [28.2%]; 127 [81.9%] considered nosocomial), Plasmodium falciparum (122 of 549 [22.2%]), and Streptococcus pneumoniae (109 of 549 [19.9%]). Other organisms, such as cytomegalovirus (57 [10.4%]) and Acinetobacter baumannii (39 [7.1%]; 35 of 39 [89.7%] considered nosocomial), also played important roles. For the top underlying causes of death, the median number of conditions in the chain of events leading to death was 3 for malnutrition, 3 for HIV, 1 for malaria, 3 for congenital birth defects, and 1 for LRTI. Expert panels considered 494 of 632 deaths (78.2%) preventable and 26 of 632 deaths (4.1%) preventable under certain conditions.Conclusions and RelevanceIn this cross-sectional study investigating causes of child mortality in the CHAMPS Network, results indicate that, in these high-mortality settings, infectious diseases continue to cause most deaths in infants and children, often in conjunction with malnutrition. These results also highlight opportunities for action to prevent deaths and reveal common interaction of various causes in the path toward death.
PLoS medicine · 2021
Background The current burden of >5 million deaths yearly is the focus of the Sustainable Development Goal (SDG) to end preventable deaths of newborns and children under 5 years old by 2030. To accelerate progression toward this goal, data are needed that accurately quantify the leading causes of death, so that interventions can target the common causes. By adding postmortem pathology and microbiology studies to other available data, the Child Health and Mortality Prevention Surveillance (CHAMPS) network provides comprehensive evaluations of conditions leading to death, in contrast to standard methods that rely on data from medical records and verbal autopsy and report only a single underlying condition. We analyzed CHAMPS data to characterize the value of considering multiple causes of death. Methods and findings We examined deaths identified from December 2016 through November 2020 from 7 CHAMPS sites (in Bangladesh, Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, and South Africa), including 741 neonatal, 278 infant, and 241 child <5 years deaths for which results from Determination of Cause of Death (DeCoDe) panels were complete. DeCoDe panelists included all conditions in the causal chain according to the ICD-10 guidelines and assessed if prevention or effective management of the condition would have prevented the death. We analyzed the distribution of all conditions listed as causal, including underlying, antecedent, and immediate causes of death. Among 1,232 deaths with an underlying condition determined, we found a range of 0 to 6 (mean 1.5, IQR 0 to 2) additional conditions in the causal chain leading to death. While pathology provides very helpful clues, we cannot always be certain that conditions identified led to death or occurred in an agonal stage of death. For neonates, preterm birth complications (most commonly respiratory distress syndrome) were the most common underlying condition (n = 282, 38%); among those with preterm birth complications, 256 (91%) had additional conditions in causal chains, including 184 (65%) with a different preterm birth complication, 128 (45%) with neonatal sepsis, 69 (24%) with lower respiratory infection (LRI), 60 (21%) with meningitis, and 25 (9%) with perinatal asphyxia/hypoxia. Of the 278 infant deaths, 212 (79%) had ≥1 additional cause of death (CoD) beyond the underlying cause. The 2 most common underlying conditions in infants were malnutrition and congenital birth defects; LRI and sepsis were the most common additional conditions in causal chains, each accounting for approximately half of deaths with either underlying condition. Of the 241 child deaths, 178 (75%) had ≥1 additional condition. Among 46 child deaths with malnutrition as the underlying condition, all had ≥1 other condition in the causal chain, most commonly sepsis, followed by LRI, malaria, and diarrheal disease. Including all positions in the causal chain for neonatal deaths resulted in 19-fold and 11-fold increases in attributable roles for meningitis and LRI, respectively. For infant deaths, the proportion caused by meningitis and sepsis increased by 16-fold and 11-fold, respectively; for child deaths, sepsis and LRI are increased 12-fold and 10-fold, respectively. While comprehensive CoD determinations were done for a substantial number of deaths, there is potential for bias regarding which deaths in surveillance areas underwent minimally invasive tissue sampling (MITS), potentially reducing representativeness of findings. Conclusions Including conditions that appear anywhere in the causal chain, rather than considering underlying condition alone, markedly changed the proportion of deaths attributed to various diagnoses, especially LRI, sepsis, and meningitis. While CHAMPS methods cannot determine when 2 conditions cause death independently or may be synergistic, our findings suggest that considering the chain of events leading to death can better guide research and prevention priorities aimed at reducing child deaths.
The Lancet. Child & adolescent health · 2024
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
The Journal of infectious diseases · 2026 · Journal Article
Cherukumilli S, Keita AM, Still W, Wei KC, et al.
The Lancet. Global health · 2026 · Journal Article
Yousafzai MT, Cornick J, Penataro Yori P, Hossain MJ, et al.
The Journal of infectious diseases · 2026 · Journal Article
Schultes OL, Hotwani A, Pavlinac PB, Hossain MJ, et al.
Paediatric and perinatal epidemiology · 2025 · Journal Article
Vyas KJ, Muir JA, Madewell ZJ, Gupta PM, et al.
PLOS global public health · 2025 · Journal Article
Mutevedzi PC, Madewell ZJ, Kotloff KL, Bassat Q, et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2025 · Journal Article
Baillie V, Dangor Z, Blau DM, Mahtab S, et al.
The Lancet. Child & adolescent health · 2024 · Observational Study
Mahtab S, Blau DM, Madewell ZJ, Ogbuanu I, et al.
PLOS global public health · 2024 · Journal Article
Garcia Gomez E, Igunza KA, Madewell ZJ, Akelo V, et al.
EClinicalMedicine · 2023 · Journal Article
Rees CA, Igunza KA, Madewell ZJ, Akelo V, et al.
JAMA network open · 2023 · Journal Article
Bassat Q, Blau DM, Ogbuanu IU, Samura S, et al.
The Lancet. Global health · 2023 · Journal Article
Madrid L, Vyas KJ, Kancherla V, Leulseged H, et al.
PLOS global public health · 2023 · Journal Article
Laufer RS, Baral R, Buchwald AG, Campbell JD, et al.
The journal of allergy and clinical immunology. Global · 2023 · Journal Article
Ortiz JR, Laufer RS, Brunwasser SM, Coulibaly F, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Journal Article
Deichsel EL, Keita AM, Verani JR, Powell H, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Journal Article
Keita AM, Doh S, Sow SO, Powell H, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Journal Article
Schwartz LM, Oshinsky J, Reymann M, Esona MD, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Journal Article
Ochieng JB, Powell H, Sugerman CE, Omore R, et al.
The American journal of tropical medicine and hygiene · 2022 · Journal Article
Keita AM, Brintz BJ, Khan AI, Taufiqul Islam M, et al.
eLife · 2022 · Journal Article
Garbern SC, Nelson EJ, Nasrin S, Keita AM, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · Journal Article
Blau DM, Baillie VL, Els T, Mahtab S, et al.
The Pediatric infectious disease journal · 2021 · Journal Article
Tapia MD, Sylla M, Driscoll AJ, Touré A, et al.
eLife · 2021 · Journal Article
Brintz BJ, Haaland B, Howard J, Chao DL, et al.
The Lancet. Global health · 2026 · Journal Article
Yousafzai MT, Cornick J, Penataro Yori P, Hossain MJ, et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2025 · Journal Article
Bokop C, Dhar N, Izu A, Thaver-Kleitman J, et al.
The Lancet. Microbe · 2024 · Journal Article
Kwatra G, Izu A, Cutland C, Akaba G, et al.
The Lancet. Child & adolescent health · 2024 · Observational Study
Mahtab S, Blau DM, Madewell ZJ, Ogbuanu I, et al.
PLOS global public health · 2024 · Journal Article
Garcia Gomez E, Igunza KA, Madewell ZJ, Akelo V, et al.
The Pan African medical journal · 2022 · Case Reports
Traore O, Guindo I, Wakrim S, N'Diaye AS, et al.
PLoS medicine · 2021 · Journal Article
Breiman RF, Blau DM, Mutevedzi P, Akelo V, et al.
PLOS global public health · 2023 · Journal Article
Laufer RS, Baral R, Buchwald AG, Campbell JD, et al.
Vaccine · 2021 · Journal Article
Laufer RS, Driscoll AJ, Baral R, Buchwald AG, et al.
The Pan African medical journal · 2021 · Case Reports
Keita AM, Zahlane M, Benjilali L, Essaadouni L
The Journal of infection · 2024 · Journal Article
Ogbuanu IU, Otieno K, Varo R, Sow SO, et al.
JAMA pediatrics · 2022 · Journal Article
Nelson EJ, Khan AI, Keita AM, Brintz BJ, et al.
The Pan African medical journal · 2021 · Case Reports
Keita AM, Zahlane M, Benjilali L, Essaadouni L
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
The journal of allergy and clinical immunology. Global · 2023 · Journal Article
Ortiz JR, Laufer RS, Brunwasser SM, Coulibaly F, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Journal Article
Keita AM, Doh S, Sow SO, Powell H, et al.